Daniel R. Kapusta

2.4k total citations
72 papers, 2.0k citations indexed

About

Daniel R. Kapusta is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, Daniel R. Kapusta has authored 72 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Cellular and Molecular Neuroscience, 37 papers in Molecular Biology and 18 papers in Physiology. Recurrent topics in Daniel R. Kapusta's work include Neuropeptides and Animal Physiology (38 papers), Receptor Mechanisms and Signaling (29 papers) and Neuroendocrine regulation and behavior (12 papers). Daniel R. Kapusta is often cited by papers focused on Neuropeptides and Animal Physiology (38 papers), Receptor Mechanisms and Signaling (29 papers) and Neuroendocrine regulation and behavior (12 papers). Daniel R. Kapusta collaborates with scholars based in United States, Brazil and Italy. Daniel R. Kapusta's co-authors include Velga A. Kenigs, Richard D. Wainford, Zohreh Soltani, Efrain Reisin, Kurt J. Varner, Howard Lippton, Sena F. Sezen, Jaw‐Kang Chang, Melissa A. Burmeister and Zbigniew K. Krowicki and has published in prestigious journals such as Gastroenterology, Journal of the American College of Cardiology and Circulation Research.

In The Last Decade

Daniel R. Kapusta

71 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel R. Kapusta United States	26	908	902	443	416	230	72	2.0k
Robert L. Zerbe United States	29	708 0.8×	428 0.5×	336 0.8×	204 0.5×	294 1.3×	49	2.3k
Ching‐Jiunn Tseng Taiwan	29	889 1.0×	475 0.5×	664 1.5×	547 1.3×	241 1.0×	112	2.4k
Jiamin Tang China	18	408 0.4×	517 0.6×	300 0.7×	287 0.7×	112 0.5×	64	1.3k
Manabu Yoshimura Japan	21	415 0.5×	281 0.3×	259 0.6×	364 0.9×	199 0.9×	121	1.5k
Catherine C.Y. Pang Canada	27	500 0.6×	514 0.6×	968 2.2×	735 1.8×	470 2.0×	123	2.4k
Garland A. Johnson United States	14	456 0.5×	328 0.4×	420 0.9×	767 1.8×	353 1.5×	20	2.4k
Kazuhide Ayajiki Japan	28	487 0.5×	381 0.4×	1.3k 3.0×	628 1.5×	289 1.3×	89	2.7k
Ulla C. Kopp United States	31	476 0.5×	245 0.3×	603 1.4×	1.3k 3.2×	206 0.9×	71	2.5k
Paula Serrão Portugal	24	728 0.8×	249 0.3×	291 0.7×	260 0.6×	149 0.6×	128	1.9k
Otto Kuchel Canada	33	857 0.9×	472 0.5×	492 1.1×	1.2k 2.9×	693 3.0×	170	3.6k

Countries citing papers authored by Daniel R. Kapusta

Since Specialization

Citations

This map shows the geographic impact of Daniel R. Kapusta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel R. Kapusta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel R. Kapusta more than expected).

Fields of papers citing papers by Daniel R. Kapusta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel R. Kapusta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel R. Kapusta. The network helps show where Daniel R. Kapusta may publish in the future.

Co-authorship network of co-authors of Daniel R. Kapusta

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel R. Kapusta. A scholar is included among the top collaborators of Daniel R. Kapusta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel R. Kapusta. Daniel R. Kapusta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Friend, Ashton J., et al.. (2021). Interactive effects of (±)-trans-U50488 and its stereoisomers with cannabinoids. Pharmacology Biochemistry and Behavior. 207. 173218–173218. 1 indexed citations

Wang, Zhuoying, et al.. (2019). Complete atrioventricular block due to timolol eye drops: a case report and literature review. BMC Pharmacology and Toxicology. 20(1). 73–73. 10 indexed citations

Polhemus, David J., Rishi Trivedi, Juan Gao, et al.. (2017). Renal Sympathetic Denervation Protects the Failing Heart Via Inhibition of Neprilysin Activity in the Kidney. Journal of the American College of Cardiology. 70(17). 2139–2153. 74 indexed citations

Soltani, Zohreh, et al.. (2013). Potential Role of Uric Acid in Metabolic Syndrome, Hypertension, Kidney Injury, and Cardiovascular Diseases: Is It Time for Reappraisal?. Current Hypertension Reports. 15(3). 175–181. 207 indexed citations

Filipeanu, Catalin M., René de Vries, A.H. Jan Danser, & Daniel R. Kapusta. (2010). Modulation of α2C adrenergic receptor temperature-sensitive trafficking by HSP90. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1813(2). 346–357. 24 indexed citations

Guggilam, Anuradha, Kaushik P. Patel, Masudul Haque, et al.. (2008). Cytokine Blockade Attenuates Sympathoexcitation in Heart Failure: Cross-Talk Between nNOS, AT-1R and Cytokines in the Hypothalamic Paraventricular Nucleus. European Journal of Heart Failure. 10(7). 625–634. 74 indexed citations

Wainford, Richard D., et al.. (2008). Central G-alpha subunit protein-mediated control of cardiovascular function, urine output, and vasopressin secretion in conscious Sprague-Dawley rats. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. 295(2). R535–R542. 9 indexed citations

Burmeister, Melissa A., Michael Ansonoff, John E. Pintar, & Daniel R. Kapusta. (2008). Nociceptin/Orphanin FQ (N/OFQ)-Evoked Bradycardia, Hypotension, and Diuresis Are Absent in N/OFQ Peptide (NOP) Receptor Knockout Mice. Journal of Pharmacology and Experimental Therapeutics. 326(3). 897–904. 16 indexed citations

Rizzi, Anna, Barbara Spagnolo, Richard D. Wainford, et al.. (2007). In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor. Peptides. 28(6). 1240–1251. 57 indexed citations

10.

Krowicki, Zbigniew K. & Daniel R. Kapusta. (2006). Tonic Nociceptinergic Inputs to Neurons in the Hypothalamic Paraventricular Nucleus Contribute to Sympathetic Vasomotor Tone and Water and Electrolyte Homeostasis in Conscious Rats. Journal of Pharmacology and Experimental Therapeutics. 317(1). 446–453. 16 indexed citations

11.

Rizzi, Anna, Remo Guerrini, Timothy Barnes, et al.. (2005). [(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a Highly Potent and Selective Agonist of the Nociceptin/Orphanin FQ Receptor. Journal of Pharmacology and Experimental Therapeutics. 312(3). 1114–1123. 28 indexed citations

12.

Calò, Girolamo, Remo Guerrini, Anna Rizzi, et al.. (2005). UFP‐101, a Peptide Antagonist Selective for the Nociceptin/Orphanin FQ Receptor. CNS Drug Reviews. 11(2). 97–112. 81 indexed citations

13.

Kapusta, Daniel R., et al.. (2004). Mechanisms Underlying the Sympathomimetic Cardiovascular Responses Elicited by γ-Hydroxybutyrate. Journal of Cardiovascular Pharmacology. 44(6). 631–638. 19 indexed citations

14.

Kapusta, Daniel R., et al.. (2002). Nociceptin/Orphanin Fq Modulates The Cardiovascular, But Not Renal, Responses To Stress In Spontaneously Hypertensive Rats. Clinical and Experimental Pharmacology and Physiology. 29(3). 254–259. 16 indexed citations

15.

Kapusta, Daniel R.. (2000). Neurohumoral effects of orphanin FQ/nociceptin: relevance to cardiovascular and renal function. Peptides. 21(7). 1081–1099. 48 indexed citations

16.

Hornby, Pamela J., Daniel R. Kapusta, & Zbigniew K. Krowicki. (1998). Potent gastric motor and cardiovascular responses to intravenously administered nociceptin in the rat. Gastroenterology. 114. A767–A767. 4 indexed citations

17.

Gümüşel, Bülent, et al.. (1997). Nociceptin: An endogenous agonist for central opioid like1 (ORL1) receptors possesses systemic vasorelaxant properties. Life Sciences. 60(8). PL141–PL145. 64 indexed citations

18.

Kapusta, Daniel R., et al.. (1993). Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves.. Journal of Pharmacology and Experimental Therapeutics. 267(1). 197–204. 35 indexed citations

19.

Kapusta, Daniel R., et al.. (1993). Central mu opioid receptor-mediated changes in renal function in conscious rats.. Journal of Pharmacology and Experimental Therapeutics. 265(1). 134–143. 22 indexed citations

20.

Kapusta, Daniel R., Susan Y. Jones, & G. F. DiBona. (1989). Role of renal nerves in excretory responses to administration of kappa agonists in conscious spontaneously hypertensive rats.. Journal of Pharmacology and Experimental Therapeutics. 251(1). 230–237. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact